Correction | Novavax and Our Partner Serum Institute of India Have Completed Submission ... - Latest Tweet by ANI

Correction | Novavax and our partner Serum Institute of India have completed submission for Emergency Use Authorization (EUA) of our protein-based COVID-19* vaccine to the South African drug regulator: Novavax— ANI (@ANI) January 10, 2022

(SocialLY brings you all the latest breaking news, fact checks and information from social media world, including Twitter (X), Instagram and Youtube. The above post contains publicly available embedded media, directly from the user's social media account and the views appearing in the social media post do not reflect the opinions of LatestLY.)